IDYA
Price
$33.68
Change
-$0.03 (-0.09%)
Updated
Nov 19, 01:43 PM (EDT)
Capitalization
2.95B
132 days until earnings call
Intraday BUY SELL Signals
KYMR
Price
$64.86
Change
+$0.55 (+0.86%)
Updated
Nov 19, 01:48 PM (EDT)
Capitalization
4.63B
92 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IDYA vs KYMR

Header iconIDYA vs KYMR Comparison
Open Charts IDYA vs KYMRBanner chart's image
IDEAYA Biosciences
Price$33.68
Change-$0.03 (-0.09%)
Volume$300
Capitalization2.95B
Kymera Therapeutics
Price$64.86
Change+$0.55 (+0.86%)
Volume$125
Capitalization4.63B
IDYA vs KYMR Comparison Chart in %
IDYA
Daily Signal:
Gain/Loss:
KYMR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IDYA vs. KYMR commentary
Nov 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Hold and KYMR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 19, 2025
Stock price -- (IDYA: $33.70 vs. KYMR: $64.38)
Brand notoriety: IDYA and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 62% vs. KYMR: 48%
Market capitalization -- IDYA: $2.95B vs. KYMR: $4.63B
IDYA [@Biotechnology] is valued at $2.95B. KYMR’s [@Biotechnology] market capitalization is $4.63B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 1 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • IDYA’s FA Score: 1 green, 4 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, IDYA is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 4 TA indicator(s) are bullish while KYMR’s TA Score has 4 bullish TA indicator(s).

  • IDYA’s TA Score: 4 bullish, 4 bearish.
  • KYMR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both IDYA and KYMR are a good buy in the short-term.

Price Growth

IDYA (@Biotechnology) experienced а +5.28% price change this week, while KYMR (@Biotechnology) price change was +1.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.45%. For the same industry, the average monthly price growth was -5.07%, and the average quarterly price growth was +66.19%.

Reported Earning Dates

IDYA is expected to report earnings on Mar 31, 2026.

KYMR is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (-1.45% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($4.63B) has a higher market cap than IDYA($2.95B). KYMR YTD gains are higher at: 60.017 vs. IDYA (31.128). KYMR has higher annual earnings (EBITDA): -267.03M vs. IDYA (-380.2M). IDYA (670M) and KYMR (665M) have equal amount of cash in the bank . IDYA has less debt than KYMR: IDYA (26.6M) vs KYMR (85.7M). KYMR has higher revenues than IDYA: KYMR (44.7M) vs IDYA (7M).
IDYAKYMRIDYA / KYMR
Capitalization2.95B4.63B64%
EBITDA-380.2M-267.03M142%
Gain YTD31.12860.01752%
P/E RatioN/AN/A-
Revenue7M44.7M16%
Total Cash670M665M101%
Total Debt26.6M85.7M31%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
PROFIT vs RISK RATING
1..100
60
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IDYAKYMR
RSI
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 6 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
76%
Bearish Trend 29 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 6 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
IDYA
Daily Signal:
Gain/Loss:
KYMR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OANMX160.310.37
+0.23%
Oakmark Institutional
MITEX16.89N/A
N/A
Matthews Asia Innovators Institutional
GAHPX29.99N/A
N/A
Goldman Sachs Emerging Markets Eq P
FOBPX20.91-0.10
-0.48%
Tributary Balanced Instl Plus
OAIEX14.90-0.12
-0.80%
Optimum International A

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with NUVL. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+1.08%
NUVL - IDYA
59%
Loosely correlated
-3.48%
NRIX - IDYA
58%
Loosely correlated
-1.02%
XENE - IDYA
58%
Loosely correlated
N/A
OCUL - IDYA
57%
Loosely correlated
-1.09%
IMTX - IDYA
57%
Loosely correlated
+8.99%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with NRIX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+0.43%
NRIX - KYMR
64%
Loosely correlated
-1.02%
VERA - KYMR
61%
Loosely correlated
-2.00%
IDYA - KYMR
54%
Loosely correlated
+1.08%
RGNX - KYMR
54%
Loosely correlated
+0.94%
NUVL - KYMR
54%
Loosely correlated
-3.48%
More